Table 5.
GC rs2282679 genotype | P interaction b | ||
---|---|---|---|
AA HR (95% CI)a |
AC + CC HR (95% CI)a |
||
Disease-Free Survival | |||
Dietary vitamin D (μg/d) | |||
Highest tertile (≥7.1) | 1.00 | 1.65 (0.97–2.82) | |
Lowest tertile (< 4.6) | 1.03 (0.58–1.83) | 1.08 (0.56–2.08) | 0.191 |
Dietary calcium (mg/d) | |||
Highest tertile (≥1120.2) | 1.00 | 1.58 (0.92–2.71) | |
Lowest tertile (< 702.1) | 1.06 (0.59–1.91) | 1.14 (0.62–2.11) | 0.355 |
Milk (g/d) | |||
Highest tertile (≥274.6) | 1.00 | 1.63 (0.92–1.84) | |
Lowest tertile (< 128.1) | 1.21 (0.68–2.16) | 0.97 (0.51–1.84) | 0.083 |
Total dairy products (g/d) | |||
Highest tertile (≥411.8) | 1.00 | 1.51 (0.87–2.60) | |
Lowest tertile (< 199.2) | 1.00 (0.57–1.77) | 0.99 (0.53–1.83) | 0.289 |
Overall Survival | |||
Dietary vitamin D (μg/d) | |||
Highest tertile (≥7.1) | 1.00 | 2.11 (1.29–3.74) | |
Lowest tertile (< 4.6) | 1.28 (0.68–2.42) | 1.11 (0.54–2.27) | 0.040 |
Dietary calcium (mg/d) | |||
Highest tertile (≥1120.2) | 1.00 | 1.93 (1.08–3.46) | |
Lowest tertile (< 702.1) | 1.55 (0.82–2.91) | 1.18 (0.59–2.35) | 0.043 |
Milk (g/d) | |||
Highest tertile (≥274.6) | 1.00 | 2.36 (1.26–4.44) | |
Lowest tertile (< 128.1) | 2.09 (1.09–4.02) | 1.26 (0.61–2.62) | 0.004 |
Total dairy products (g/d) | |||
Highest tertile (≥411.8) | 1.00 | 2.03 (1.11–3.72) | |
Lowest tertile (< 199.2) | 1.77 (0.94–3.33) | 1.27 (0.63–2.58) | 0.024 |
Abbreviations: HR hazard rate ratios, CI confidence interval
aAdjusted for sex, age at diagnosis, stage at diagnosis, marital status, race, reported chemoradiotherapy, MSI status, BRAF mutation status, tumor location, body mass index where applicable
bP for interaction is computed with Wald method testing significance of multiplicative interaction term between GC SNP rs2282679 genotype and respective stratified variable
Those with P < 0.05 are in bold